The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis

What do we know regarding its pharmacokinetics?

Nelson Leung, Thomas Elmer Witzig

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2586-2587
Number of pages2
JournalLeukemia and Lymphoma
Volume54
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Radioimmunotherapy
Follicular Lymphoma
Dialysis
Pharmacokinetics
Monoclonal Antibodies
ibritumomab tiuxetan

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis : What do we know regarding its pharmacokinetics? / Leung, Nelson; Witzig, Thomas Elmer.

In: Leukemia and Lymphoma, Vol. 54, No. 12, 12.2013, p. 2586-2587.

Research output: Contribution to journalArticle

@article{d066db037443416cad49b387bbc1ee8f,
title = "The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis: What do we know regarding its pharmacokinetics?",
author = "Nelson Leung and Witzig, {Thomas Elmer}",
year = "2013",
month = "12",
doi = "10.3109/10428194.2013.809530",
language = "English (US)",
volume = "54",
pages = "2586--2587",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis

T2 - What do we know regarding its pharmacokinetics?

AU - Leung, Nelson

AU - Witzig, Thomas Elmer

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84887226511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887226511&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.809530

DO - 10.3109/10428194.2013.809530

M3 - Article

VL - 54

SP - 2586

EP - 2587

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 12

ER -